Home › Compare › PEAK vs MRK

PEAK vs MRK: Dividend Comparison 2026

PEAK yields 7.02% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $6.4K in total portfolio value· pulled ahead in Year 3
10 years
PEAK
PEAK
● Live price
7.02%
Share price
$17.10
Annual div
$1.20
5Y div CAGR
-17.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.3K
Annual income
$121.62
Full PEAK calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — PEAK vs MRK

📍 MRK pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPEAKMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PEAK + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PEAK pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PEAK
Annual income on $10K today (after 15% tax)
$596.49/yr
After 10yr DRIP, annual income (after tax)
$103.38/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MRK beats the other by $704.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PEAK + MRK for your $10,000?

PEAK: 50%MRK: 50%
100% MRK50/50100% PEAK
Portfolio after 10yr
$27.5K
Annual income
$535.96/yr
Blended yield
1.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PEAK
Analyst Ratings
15
Buy
17
Hold
1
Sell
Consensus: Hold
Price Target
$30.82
+80.2% upside vs current
Range: $19.00 — $40.00
Altman Z
0.7
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PEAK buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPEAKMRK
Forward yield7.02% ✓3.25%
Annual dividend / share$1.20$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR-17.8%8.2% ✓
Portfolio after 10y$24.3K$30.7K ✓
Annual income after 10y$121.62$950.29 ✓
Total dividends collected$3.1K$6.1K ✓
Payment frequencyquarterlyquarterly
SectorREITHealthcare
Analyst consensusHoldBuy
Analyst price target$30.82$128.54 ✓

Year-by-year: PEAK vs MRK ($10,000, DRIP)

YearPEAK PortfolioPEAK Income/yrMRK PortfolioMRK Income/yrGap
1$11,277$576.84$11,192$351.54+$85.00 → PEAK
2$12,566$499.73$12,524$392.70+$42.00 → PEAK
3← crossover$13,873$427.79$14,015$438.65$142.00 → MRK
4$15,207$362.83$15,682$489.96$475.00 → MRK
5$16,577$305.54$17,547$547.23$970.00 → MRK
6$17,994$255.87$19,632$611.16$1.6K → MRK
7$19,467$213.36$21,963$682.53$2.5K → MRK
8$21,007$177.32$24,571$762.18$3.6K → MRK
9$22,624$147.00$27,486$851.08$4.9K → MRK
10$24,329$121.62$30,745$950.29$6.4K → MRK

PEAK vs MRK: Complete Analysis 2026

PEAK — REIT

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.

Full PEAK Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this PEAK vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PEAK vs SCHDPEAK vs JEPIPEAK vs OPEAK vs KOPEAK vs MAINPEAK vs JNJPEAK vs ABBVPEAK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.